Plasma paraoxonase 1 arylesterase activity in D-galactose-induced aged rat model: Correlation with LDL oxidation and redox status

Aging Clinical and Experimental Research

Volumn 26, Issue 3, 2014, Pages 261-267

  Kumar, Dileep ^a   Rizvi, Syed Ibrahim ^a  

^a UNIVERSITY OF ALLAHABAD   (India)

Author keywords

Aging model; D galactose; Oxidative stress; PON1 arylesterase activity

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; GALACTOSE; LOW DENSITY LIPOPROTEIN; RADICAL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKER; OXIDIZED LOW DENSITY LIPOPROTEIN; PON 1 PROTEIN, RAT;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; RAT; ANIMAL; ANIMAL MODEL; BLOOD; DRUG EFFECTS; METABOLISM; OXIDATION REDUCTION REACTION; WISTAR RAT;

AGING; ANIMALS; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; GALACTOSE; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MODELS, ANIMAL; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84902009316     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/s40520-013-0170-2     Document Type: Article

References (50)

1. Kawakami K, Kadota J, Iida K, Shirai R, Abe K, Kohno S (1999) Reduced immune function and malnutrition in the elderly. Tohoku J Exp Med 187:157-171
2. Harman D (2006) Free radical theory of aging: an update: increasing the functional life span. Ann N Y Acad Sci 1067:10-21
3. Xu FB (1985) Sub-acute toxicity of D-galactose. In: Proceedings of the Second National Conference on Aging Research. Herbin China
4. Zhang X, Li WB, Zhang BL (1990) Biochemical changes in D-galactose induced subacute toxicity and mimetic aging in mice. Chin J Pharmacol Toxicol 4:309-310
5. Zheng JY, Fu YR, Li M, Gao KS, Zhang XG (2009) Effect of LTA isolated from bifidobacteria on D-galactose-induced aging. Exp Gerontol 44:760-765
6. Cui X, Zuo P, Zhang Q, Li X, Hu Y, Long J, Packer L, Liu J (2006) Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-alpha-lipoic acid. J Neurosci Res 84:647-654 (Pubitemid 44196705)
7. Zhang Q, Li XK, Cui X, Zuo PP (2009) D-galactose injured neurogenesis in the hippocampus of adult mice. Neurol Res 27:552-556 (Pubitemid 41040845)
8. Yanar K, Aydin S, Cakatay U, Mengi M, Buyukpinarbas N, A-tukeren P, Sitar ME, Sonmez A, Uslu E (2011) Protein and DNA oxidation in different anatomic regions of rat brain in a mimetic ageing model. Basic Clin Pharmacol Toxicol 109(6):423-433
9. Durrington PN, Mackness B, Mackness MI (2001) Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 21:473-480 (Pubitemid 32323376)
10. Goswami B, Tayal D, Gupta N, Mallika V (2009) Paraoxonase: a multifaceted biomolecule. Clin Chim Acta 410:1-12
11. Van Lenten BJ, Wagner AC, Nayak DP, Hama S, Navab M, Fogelman AM (2001) High-density lipoprotein loses its anti-inflammatory properties during acute influenza infection. Circulation 103:2283-2288 (Pubitemid 32433719)
12. Cherki M, Berrougui H, Isabelle M, Cloutier M, Koumbadinga GA, Khalil A (2007) Effect of PON1 polymorphism on HDL antioxidant potential is blunted with aging. Exp Gerontol 42:815-824 (Pubitemid 47058863)
13. La Du BN (1996) Structural and functional diversity of paraoxonases. Nat Med 2:1186-1187
14. Nguyen DS, Sok DE (2003) Oxidative inactivation of paraoxonase 1, an antioxidant protein and its effect on antioxidant action. Free Radic Res 37:1319-1330 (Pubitemid 37441715)
15. Berliner JA, Heinecke JW (1996) The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20:707-727 (Pubitemid 26105783)
16. Marathe GK, Zimmerman GA, McIntyre TM (2003) Platelet activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles. J Biol Chem 278:3937-3947 (Pubitemid 36801125)
17. Mehdi MM, Rizvi SI (2012) Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation. Arch Med Res 43:438-443
18. Mehdi MM, Rizvi SI (2012) Plasma protein hydroperoxides during aging in humans: correlation with paraoxonase 1 (PON1) arylesterase activity and plasma total thiols. Arch Med Res 44:136-141
19. Sheng-lang J, Yong-guang Y (2012) In vivo antioxidant activity of total flavonoids from indocalamus leaves in aging mice caused by D-galactose. Food Chem Toxicol 50:3814-3818
20. Song X, Mingmin B, Diandong L, Yong LM (1999) Advanced glycation in D-galactose induced mouse aging model. Mech Ageing Dev 108:239-251 (Pubitemid 29240629)
21. Ayub A, Mackness MI, Arrol S, Mackness B, Patel J, Durrington PN (1999) Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol 19:330-335 (Pubitemid 29072747)
22. Schnitzer E, Pinchuk I, Bor A, Fainaru M, Samuni AM, Lichtenberg D (1998) Lipid oxidation in unfractionated serum and plasma. Chem Phys Lipids 92:151-170 (Pubitemid 28327447)
23. Szabo MR, Iditoiu C, Chambre D, Lupea AX (2007) Improved DPPH determination for antioxidant activity spectrophotometric assay. Chem Paper 61:214-216
24. Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malondialdehyde and 4-hydroxynonenal. Methods Enzymol 186:407-413
25. Wei H, Li L, Song Q, Ai H, Chu J, Li W (2005) Behavioural study of the D-galactose induced aging model in C57BL/6Jmice. Behav Brain Res 157:245-251 (Pubitemid 40082567)
26. Moyer JR Jr, Furtak SC, McGann JP, Brown TH (2009) Aging-related changes in calcium-binding proteins in rat perirhinal cortex. Neurobiol Aging 32:1693-1706
27. Kong WJ, Wang Y, Wang Q, Hu YJ, Han YC, Liu J (2006) The relation between D-galactose injection and mitochondrial DNA 4834 bp deletion mutation. Exp Gerontol 41:628-634 (Pubitemid 43867227)
28. Hua X, Lei M, Zhang Y, Ding J, Han Q, Hu G, Xiao M (2007) Long-term D-galactose injection combined with ovariectomy serves as a new rodent model for Alzheimer' disease. Life Sci 80:1897-1905 (Pubitemid 46560732)
29. Parameshwaran K, Irwin MH, Steliou K, Pinkert CA (2010) D-galactose effectiveness in modeling aging and therapeutic antioxidant treatment in mice. Rejuvenation Res 13:729-735
30. Lei M, Hua X, Xiao M, Han Q, Hu G (2008) Impairments of astrocytes are involved in the D-galactose induced brain aging. Biochem Biophys Res Commun 369:1082-1087
31. Santanam N, Parthasarathy S (2007) Aspirin is a substrate for paraoxonase-like activity: implications in atherosclerosis. Atherosclerosis 191:272-275 (Pubitemid 46415635)
32. Tsuzura S, Ikeda Y, Suehiro T, Ota K, Osaki F, Arii K, Kumon Y, Hashimoto K (2004) Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes. Metabolism 53:297-302 (Pubitemid 38684688)
33. Jaouad L, Milochevitch C, Khalil A (2003) PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity. Free Radic Res 37:77-83 (Pubitemid 36124333)
34. Li WF, Furlong CE, Costa LG (1995) Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol Lett 76:219-226
35. Costa LG, Vitalone A, Cole TB, Furlong CE (2005) Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69:541-550
36. Van Himbergen TM, van der Schouw YT, Voorbij HA, van Tits LJ, Stalenhoef AF, Peeters PH, Roest M (2008) Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women. Atherosclerosis 199:408-414
37. Ozturk H, Gungor M, Yigit S, Tacyildiz H, Basinoglu F, Koldas M (2009) Effect of exercise on the paraoxonase activity. Clin Biochem 42:343-346
38. La Du BN, Aviram M, Billecke S, Navab M, Primo-Parmo S, Sorenson RC, Standiford TJ (1999) On the physiological role(s) of the paraoxonases. Chem Biol Interact 14(119-120):379-388 (Pubitemid 29278574)
39. Costa LG, Giordano G, Cole TB, Marsillach J, Furlong CE (2013) Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity. Toxicol 10(307):115-122
40. Tavori H, Aviram M, Khatib S, Musa R, Nitecki S, Hoffman A, Vaya J (2009) Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects. Free Radic Biol Med 46:607-615
41. Mackness B, Durrington PN, Boulton AJM, Hine D, Mackness MI (2002) Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls. Eur J Clin Invest 32:259-264 (Pubitemid 36216591)
42. Unal E, Uzun H, Kusaslan R, Dogan M, Genc H, Gunes P, Titiz I (2005) Serum paraoxonase (a high-density lipoprotein-associated lipophilic antioxidant) activity and lipid profile in experimental acute pancreatitis. Pancreas 31:84-87 (Pubitemid 40911508)
43. Marchegiani F, Mara M, Oliveri F, Cardelli M, James RW, Boemi M, Franceschi C (2008) Paraoxonase 1: genetics and activities during aging. Rejuvenation Res 11:113-127 (Pubitemid 351271629)
44. Polat D, Ezgi D, Ahmet B, Hakan Y (2006) Decreased serum paraoxonase 1 (PON1) activity: an additional risk factor for atherosclerotic heart disease in patients with PCOS? Hum Reprod 21:104-108
45. Caroline AA, Michael IM, Sudhesh K, Andrew JB, Paul ND (1995) Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol 15:1812-1818
46. Jaouad L, de Guise C, Berrougui H, Cloutier M, Isabelle M, Fulop T, Payette H, Khalil A (2006) Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydryl groups. Atherosclerosis 185:191-200 (Pubitemid 43117568)
47. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN (1998) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101:1581-1590 (Pubitemid 28198486)
48. Mackness B, Durrington PN, Mackness MI (1998) Review human serum paraoxonase. Gen Pharmacol 31:329-336
49. Rozenberg O, Aviram M (2006) S-Glutathionylation regulates HDL associated paraoxonase 1 (PON1) activity. Biochem Biophys Res Commun 351:492-498 (Pubitemid 44666714)
50. Ates O, Azizi S, Alp HH, Kiziltunc A, Kocer I, Baykal O (2009) Decreased serum paraoxonase 1 activity and increased serum homocysteine and malondialdehyde levels in age-related macular degeneration. Tohoku J Exp Med 217:17-22